Oncology Expansion: Sakar Healthcare Secures 11 Global Drug Approvals

Sakar Healthcare Limited has received eleven marketing authorizations for oncology drugs across Europe and emerging markets. These approvals, granted after rigorous audits and dossier evaluations, will enable the company to export and commercialize key cancer treatments internationally. The move strengthens Sakar’s global footprint and signals a strategic leap in oncology care.

Show more

Stay Ahead – Explore Now! Mark Your Calendars! Capital Trust’s Rights Issue Record Date Gets a Game-Changing Update